2Guadagni F, Roselli M, Cosimelli M, et al. TAG - 72 ( CA72 - 4 assay) as a complementary serum tumor antigen to carcinoembryonic antigen in monitoring patients with colorectal cancer. Cancer. 1993,72:2098.
1Attili S V,Ananda B,Mandapal T,et al.Factors influencing progression-free survival in gastrointestinal stromal tumors with special reference to pathologic features,cytogenetics,and radiologic response[J].Gastrointest Cancer Res,2011,4(5):173-177.
3Talar-Wojnarowska R, Gasiorowska A, Olakowski M, et al. Clinical value of serum nepoterm ,tissue polypeptidespecific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreati- tis[J]. Pancreatology, 2010,10 (6) : 689-694.
4Tanaka K,Yano M, Motoori M, et al. CEA-antigen and SCC-antigen mRNA expression in peripheral blood predict hematogenous recurrence after re- section in patients with esophageal cancer[J]. Ann Surg Onco1,2010,17 (10) : 2779-2786.
5Zhu YB, Ge SH,Zhang LH, et al. Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer[J].Chin J Gastroenterol Hepatol,2012,15(2) : 161-164.
6Zhu YB, Ge SH, Zhang LH, et a l.Clinical value of serum CEA, CA19-9, CA724 and CA242 in the diagnosis and prognosis of gastric cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2012,15 ( 2 ) : 161 - 164.
7Cidon EU, Bustamante R. Gastric cancer:tumor marker as factors for pre- operative staging[J]. J Gastrointest Cancer, 2010,42 (3) : 142-130.
